Rare diseases
Investigational molecules
Locations
Back to the Netherlands31 clinical trials in Haarlem, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on the Use of Flortaucipir for Diagnosing Mild Cognitive Impairment and Dementia in Patients
The NetherlandsStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
The NetherlandsStudy Comparing Radiofrequency Ablation and Sodium Iodide (131I) for Treating Hyperthyroidism in Patients with Overactive Thyroid Nodules
The NetherlandsA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
The NetherlandsStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
The NetherlandsStudy on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease
The NetherlandsStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
The NetherlandsStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
The NetherlandsStudy of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides
The NetherlandsEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
The NetherlandsLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
The NetherlandsStudy on Personalized Dosing of Natalizumab for Patients with Relapsing-Remitting Multiple Sclerosis
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for heart failure prevention and management of cardiovascular diseases. Studies include evaluation of new medications for reducing cardiac events and improving outcomes in patients with established heart conditions.
Advanced research combining established treatments with novel therapeutic approaches to enhance cardiovascular health outcomes.
Comprehensive studies addressing Type 2 Diabetes and obesity, investigating innovative treatments and their impact on cardiovascular outcomes. Research focuses on testing new therapeutic agents for improved metabolic control.
Integration of novel therapeutic approaches with established treatments for better metabolic disease management.
Research initiatives examining treatments for multiple sclerosis and stroke prevention. Studies include personalized dosing strategies and evaluation of antiplatelet therapy effectiveness in young stroke patients.
Focus on developing targeted therapies and optimizing treatment protocols for neurological conditions.
Studies investigating treatments for various cancers, including colorectal liver metastases and esophageal adenocarcinoma. Research includes evaluation of targeted therapies and combination treatment approaches.
Development of innovative therapeutic strategies to improve cancer treatment outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
